Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Aug 19;8(8):CD003150.
doi: 10.1002/14651858.CD003150.pub3.

Aromatherapy for dementia

Emily L Ball #  1 , Bethan Owen-Booth #  2   3 , Amy Gray  4 , Susan D Shenkin  5 , Jonathan Hewitt  6 , Jenny McCleery  7
Affiliations
Meta-Analysis

Aromatherapy for dementia

Emily L Ball et al. Cochrane Database Syst Rev. .

Abstract

Background: Medications licensed for the treatment of dementia have limited efficacy against cognitive impairment or against the distressed behaviours (behavioural and psychological symptoms, or behaviour that challenges) which are also often the most distressing aspect of the disorder for caregivers. Complementary therapies, including aromatherapy, are attractive to patients, practitioners and families, because they are perceived as being unlikely to cause adverse effects. Therefore there is interest in whether aromatherapy might offer a safe means of alleviating distressed behaviours in dementia.

Objectives: To assess the efficacy and safety of aromatherapy for people with dementia.

Search methods: We searched ALOIS, the Cochrane Dementia and Cognitive Improvement Group Specialized Register, on 5 May 2020 using the terms: aromatherapy, lemon, lavender, rose, aroma, alternative therapies, complementary therapies, essential oils. In addition, we searched MEDLINE, Embase, PsycINFO (all via Ovid SP), Web of Science Core Collection (via Thompson Web of Science), LILACS (via BIREME), CENTRAL (via the Cochrane Library), ClinicalTrials.gov and the World Health Organization (WHO) trials portal (ICTRP) on 5 May 2020.

Selection criteria: We included randomised controlled trials which compared fragrance from plants in an intervention defined as aromatherapy for people with dementia with placebo aromatherapy or with treatment as usual. All doses, frequencies and fragrances of aromatherapy were considered. Participants in the included studies had a diagnosis of dementia of any subtype and severity.

Data collection and analysis: Two reviewers independently selected studies for inclusion, extracted data and assessed risk of bias in included studies, involving other authors to reach consensus decisions where necessary. We did not perform any meta-analyses because of heterogeneity between studies, but presented a narrative synthesis of results from the included trials. Because of the heterogeneity of analysis methods and inadequate or absent reporting of data from some trials, we used statistical significance (P ≤ or > 0.5) as a summary metric when synthesising results across studies. As far as possible, we used GRADE methods to assess our confidence in the results of the trials, downgrading for risk of bias and imprecision.

Main results: We included 13 studies with 708 participants. All participants had dementia and in the 12 trials which described the setting, all were resident in institutional care facilities. Nine trials recruited participants because they had significant agitation or other behavioural and psychological symptoms in dementia (BPSD) at baseline. The fragrances used were lavender (eight studies); lemon balm (four studies); lavender and lemon balm, lavender and orange, and cedar extracts (one study each). For six trials, assessment of risk of bias and extraction of results was hampered by poor reporting. Four of the other seven trials were at low risk of bias in all domains, but all were small (range 18 to 186 participants; median 66), reducing our confidence in the results. Our primary outcomes were agitation, overall behavioural and psychological symptoms, and adverse effects. Ten trials assessed agitation using various scales. Among the five trials for which our confidence in the results was moderate or low, four trials reported no significant effect on agitation and one trial reported a significant benefit of aromatherapy. The other five trials either reported no useable data or our confidence in the results was very low. Eight trials assessed overall BPSD using the Neuropsychiatric Inventory and we had moderate or low confidence in the results of five of them. Of these, four reported significant benefit from aromatherapy and one reported no significant effect. Adverse events were poorly reported or not reported at all in most trials. No more than two trials assessed each of our secondary outcomes of quality of life, mood, sleep, activities of daily living, caregiver burden. We did not find evidence of benefit on these outcomes. Three trials assessed cognition: one did not report any data and the other two trials reported no significant effect of aromatherapy on cognition. Our confidence in the results of these studies was low.

Authors' conclusions: We have not found any convincing evidence that aromatherapy (or exposure to fragrant plant oils) is beneficial for people with dementia although there are many limitations to the data. Conduct or reporting problems in half of the included studies meant that they could not contribute to the conclusions. Results from the other studies were inconsistent. Harms were very poorly reported in the included studies. In order for clear conclusions to be drawn, better design and reporting and consistency of outcome measurement in future trials would be needed.

Trial registration: ClinicalTrials.gov NCT02126059 NCT03108781.

PubMed Disclaimer

Conflict of interest statement

ELB ‐ none known

BO‐B ‐ none known

JH ‐ none known

SDS ‐ none known

AG ‐ none known

JMcC ‐ none known

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Ballard 2002 {published data only}
    1. Ballard CG, O'Brien JT, Reichelt K, Perry EK. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind placebo-controlled trial with Melissa. Journal of Clinical Psychiatry 2002;63(7):553-8. - PubMed
    1. Lee L, Reichelt K, Ballard C, Perry E. Melissa aromatherapy as safe and effective treatment. Nursing & Residential Care 2003;5(2):80-2.
Burns 2011 {published data only}
    1. Burns A, Perry E, Holmes C, Francis P, Morris J, Howes MJR, et al. A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders 2011;31(2):158-64. - PubMed
Cameron 2011 {published data only}
    1. Cameron H, du Toit S, Richard G, Bearns L. Using lemon balm oil to reduce aggression and agitation in dementia: results of a pilot study. Journal of Dementia Care 2011;19(5):36-8.
Fu 2013 {published data only}
    1. Fu CY, Moyle W, Cooke M. A randomised controlled trial of the use of aromatherapy and hand massage to reduce disruptive behaviour in people with dementia. BMC Complementary and Alternative Medicine 2013;13:165. - PMC - PubMed
Fujii 2008 {published data only}
    1. Fujii M, Hatakeyama R, Fukuoka Y, Yamamoto T, Sasaki R, Moriya M, et al. Lavender aroma therapy for behavioral and psychological symptoms in dementia patients. Geriatrics & Gerontology International 2008;8(2):136-8. - PubMed
Hanson 2013 {published data only}
    1. Hanson L, Cagan A, Rinehimer K, Flottemesch T, Clairmont J, Sackett-Lundeen L, et al. Lavender essential oil improves sleep in residents of a memory care assisted living facility. In: Alzheimer's & Dementia. Vol. 9 (issue 4, supplement). 2013:P655-6.
    1. Hanson L, Cagan A, Rinehimer K, Stuck L, Flottemesch T, Clairmont J, et al. Lavender essential oil improved sleep in residents of a memory care assisted living facility (Poster). englishrosesuites.com/wp-content/uploads/2018/10/AAIC-2013-Lavender-Esse....
Lin 2007 {published data only}
    1. Lin PW-K, Chan W-C, Ng BF-L, Lam LC-W. Efficacy of aromatherapy (Lavandula angustifolia) as an intervention for agitated behaviours in Chinese older persons with dementia: A cross-over randomized trial. International Journal of Geriatric Psychiatry 2007;22(5):405-10. - PubMed
O'Connor 2013 {published data only}
    1. O’Connor DW, Eppingstall B, Taffe J, Ploeg ES. A randomized, controlled cross-over trial of dermally-applied lavender (Lavandula angustifolia) oil as a treatment of agitated behaviour in dementia. BMC Complementary and Alternative Medicine 2013;13(1):315. - PMC - PubMed
    1. Ploeg ES, Eppingstall B, O'Connor DW. The study protocol of a blinded randomised-controlled cross-over trial of lavender oil as a treatment of behavioural symptoms in dementia. BMC Geriatrics 2010;10(1):49. - PMC - PubMed
Smallwood 2001 {published data only}
    1. Smallwood J, Brown R, Coulter F, Irvine E, Copland C. Aromatherapy and behaviour disturbances in dementia: a randomized controlled trial. International Journal of Geriatric Psychiatry 2001;16(10):1010-3. - PubMed
Takahashi 2020 {published data only}
    1. Takahashi Y, Shindo S, Kanbayashi T, Takeshima M, Imanishi A, Mishima K. Examination of the influence of cedar fragrance on cognitive function and behavioural and psychological symptoms of dementia in Alzheimer type dementia. Neuropsychopharmacology Reports 2020;40(1):10-5. - PMC - PubMed
Watson 2019 {published data only}
    1. Watson K, Hatcher D, Good A. A randomised controlled trial of lavender (lavandula angustifolia) and lemon balm (melissa officinalis) essential oils for the treatment of agitated behaviour in older people with and without dementia. Complementary Therapies in Medicine 2019;42:366-73. - PubMed
Yang 2015 {published data only}
    1. ChiCTR-TRC-14004810. Comparison of aroma-acupressure and aromatherapy in improving the problem behaviours of dementia. chictr.org.cn/historyversionpuben.aspx?regno=ChiCTR-TRC-14004810 (first received 01 May 2015).
    1. Yang MH, Lin LC, Wu SC, Chiu JH, Wang PN, Lin JG. Comparison of the efficacy of aroma-acupressure and aromatherapy for the treatment of dementia-associated agitation. BMC Complementary and Alternative Medicine 2015;15(1):93. [DOI: 10.1186/s12906-015-0612-9] - DOI - PMC - PubMed
Yang 2016 {published data only}
    1. NCT02126059. Complementary interventions on patients with dementia: comparative and longitudinal research [The health effects of cognitive stimulation, reminiscence and aroma-massage complementary interventions on different behavior patterns of patients with dementia]. clinicaltrials.gov/ct2/show/NCT02126059 (first received 29 April 2014).
    1. Yang YP, Lee FP, Chao HC, Hsu FY, Wang JJ. Comparing the effects of cognitive stimulation, reminiscence and aroma-massage on agitation and depressive mood in people with dementia. Journal of the American Medical Directors Association 2016;17(8):719-24. - PubMed
    1. Yang YP, Wang CJ, Wang JJ. Effect of aromatherapy massage on agitation and depressive mood in individuals with dementia. Journal of Gerontological Nursing 2016;42(9):38-46. - PubMed

References to studies excluded from this review

Akhondzadeh 2003 {published data only}
    1. Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry 2003;74(7):863-6. - PMC - PubMed
Bowles 2002 {published data only}
    1. Bowles EJ, Griffiths DM, Quirk L, Brownrigg A, Croot K. Effects of essential oils and touch on resistance to nursing care procedures and other dementia related behaviours in a residential care facility. International Journal of Aromatherapy 2002;12(1):22-9.
Brooker 1997 {published data only}
    1. Brooker DJR, Snape M, Johnson E, Ward E, Payne M. Single case evaluation of the effects of aromatherapy and massage on disturbed behaviour in severe dementia. British Journal of Clinical Psychology 1997;36(2):287-96. - PubMed
Burleigh 1997 {published data only}
    1. Burleigh S, Armstrong C. On the scent of a useful therapy. Journal of Dementia Care 1997;July/August:21-3.
Chiayana 2012 {published data only}
    1. Chaiyana W, Okonogi S. Inhibition of cholinesterase by essential oil from food plant. Phytomedicine 2012;19(8-9):836-9. - PubMed
Cohen‐Mansfield 2012a {published data only}
    1. Cohen-Mansfield J, Thein K, Marx MS, Dakheel-Ali M, Murad H, Freedman LS. The relationships of environment and personal characteristics to agitated behaviors in nursing home residents with dementia. Journal of Clinical Psychiatry 2012;73:392-9. - PubMed
Cohen‐Mansfield 2012b {published data only}
    1. Cohen-Mansfield J, Marx MS, Freedman LS, Murad H, Thein K, Dakheel-Ali M. What affects pleasure in persons with advanced stage dementia? Journal of Psychiatric Research 2012;46(3):402-6. - PMC - PubMed
Cooper 2012 {published data only}
    1. Cooper C, Mukadam N, Katona C, Lyketsos CG, Ames D, Rabins P, et al. Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementia. International Psychogeriatrics 2012;24:856-70. - PubMed
Dimitriou 2018 {published data only}
    1. Dimitriou TD, Verykouki E, Papatriantafyllou J, Konsta A, Kazis D, Tsolaki M. Non-pharmacological interventions for agitation/aggressive behaviour in patients with dementia: a randomized controlled crossover trial. Functional neurology 2018;33(3):143-7. - PubMed
Farokhnia 2014 {published data only}
    1. Farokhnia M, Shafiee Sabet M, Iranpour N, Gougol A, Yekehtaz H, Alimardani R, et al. Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial. Human Psychopharmacology 2014;29(4):351-9. - PubMed
Fung 2012 {published data only}
    1. Fung KM, Tsang HW, Chung RC. A systematic review of the use of aromatherapy in treatment of behavioral problems in dementia. Geriatrics & Gerontology International 2012;12(3):372-82. - PubMed
Fung 2018 {published data only}
    1. Fung JKK-M, Tsang HW-H. Management of behavioural and psychological symptoms of dementia by an aroma-massage with acupressure treatment protocol: a randomised clinical trial. Journal of clinical nursing 2018;27(9-10):1812-25. - PubMed
Gray 2002 {published data only}
    1. Gray SG, Clair AA. Influence of aromatherapy on medication administration to residential-care residents with dementia and behavioural challenges. American Journal of Alzheimer's Disease & Other Dementias 2002;17(3):169-74. - PMC - PubMed
Guendling 2010 {published data only}
    1. Guendling A, Guendling PW. Aromatherapy in dementia. In: European Journal of Integrative Medicine. Vol. Conference: 3rd European Congress for Integrative Medicine, ECIM 2010 Berlin Germany. Conference Start: 20101203 Conference End: 20101204. Conference Publication. 2010:227.
Henry 1993 {published data only}
    1. Henry J. Aroma groups improve the quality of life in Alzheimer's disease. The International Journal of Aromatherapy 1993;5(1):27-9.
Holmes 2002 {published data only}
    1. Holmes C, Hopkins V, Hensford C, MacLaughlin V, Wilkinson D, Rosenvinge H. Lavender oil as a treatment for agitated behaviour in severe dementia. International Journal of Geriatric Psychiatry 2002;17(4):305-8. - PubMed
Jimbo 2009 {published data only}
    1. Jimbo D, Kimura Y, Taniguchi M, Inoue M, Urakami K. Effect of aromatherapy on patients with Alzheimer's disease. Psychogeriatrics 2009;9(4):173-9. - PubMed
Kaufmann 2011 {published data only}
    1. Kaufmann D, Dogra AK, Wink M. Myrtenal inhibits acetylcholinesterase, a known Alzheimer target. Journal of Pharmacy and Pharmacology 2011;63(10):1368-71. - PubMed
Kaymaz 2017 {published data only}
    1. Kaymaz TT, Ozdemir L. Effects of aromatherapy on agitation and related caregiver burden in patients with moderate to severe dementia: A pilot study. Geriatric Nursing 2017;38(3):231-7. - PubMed
Kilstoff 1998 {published data only}
    1. Kilstoff K, Chenoweth L. New approaches to health and well-being for dementia day-care clients, family carers and day-care staff. International Journal of Nursing Practice 1998;4(2):70-83. - PubMed
Kimura 2013 {published data only}
    1. Kimura T, Takamatsu J. Pilot study of pharmacological treatment for frontotemporal lobar degeneration: Effect of lavender aroma therapy on behavioral and psychological symptoms. Geriatrics & Gerontology International 2013;13(2):516-7. [DOI: 10.1111/ggi.12025] - DOI - PubMed
Klages 2011 {published data only}
    1. Klages K, Zecevic A, Orange JB, Hobson S. Potential of Snoezelen room multisensory stimulation to improve balance in individuals with dementia: a feasibility randomized controlled trial. Clinical Rehabilitation 2011;25(7):607-16. - PubMed
Korn 2012 {published data only}
    1. Korn L, Logsdon R, Polissar N, Gomez-Beloz A, Waters T, Ryser R. A randomized trial of polarity therapy for stress and pain reduction in American Indian and Alaska Native family dementia caregivers. In: BMC Complementary and Alternative Medicine. Vol. Conference: International Research Congress on Integrative Medicine and Health 2012 Portland, OR United States. Conference Start: 20120515 Conference End: 20120518. Conference Publication. 2012:1.
Li 2017 {published data only}
    1. Li RM, Gilbert B, Orman A, Aldridge P, Leger-Krall S, Anderson C, Castillo JH. Evaluating the effects of diffused lavender in an adult day care center for patients with dementia in an effort to decrease behavioral issues: a pilot study. Journal of Drug Assessment 2017;6(1):1. - PMC - PubMed
Lucian 2012 {published data only}
    1. Hritcu L, Cioanca O, Hancianu M. Effects of lavender oil inhalation on improving scopolamine-induced spatial memory impairment in laboratory rats. Phytomedicine 2012;19(6):529-34. - PubMed
MacMahon 1998 {published data only}
    1. MacMahon S, Kermode S. A clinical trial of the effects of aromatherapy on motivational behaviour in a dementia care setting using a single subject design. The Australian Journal of Holistic Nursing 1998;5(2):47-9. - PubMed
Mitchell 1993 {published data only}
    1. Mitchell S. Aromatherapy's effectiveness in disorders associated with dementia. The International Journal of Aromatherapy 1993;5(2):20-3.
Moss 2003 {published data only}
    1. Moss M, Cook J, Wesnes K, Duckett P. Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults. The International Journal of Neuroscience 2003;113(1):15-38. - PubMed
NCT02518243 {published data only}
    1. NCT02518243. Safe and easy for Alzheimer's disease and related pathologies. clinicaltrials.gov/ct2/show/NCT02518243 (first received 07 August 2015). [https://clinicaltrials.gov/ct2/show/NCT02518243]
Ogun‐Semore 2019 {published data only}
    1. Ogun-Semore OY. Lavender aromatherapy for agitation in elderly with dementia: A clinical scholarly project [Doctoral thesis]. ProQuest LLC, 2019.
Opie 1999 {published data only}
    1. Opie J, Rosewarne R, O'Connor DW. The efficacy of psychosocial approaches to behaviour disorders in dementia: a systematic literature review. Australian and New Zealand Journal of Psychiatry 1999;33(6):789-99. - PubMed
Pengelly 2012 {published data only}
    1. Pengelly A, Snow J, Mills SY, Scholey A, Wesnes K, Butler LR. Short-term study on the effects of rosemary on cognitive function in an elderly population. Journal of Medicinal Food 2012;15(1):10-7. - PubMed
Sakamoto 2012 {published data only}
    1. Sakamoto Y, Ebihara S, Ebihara T, Tomita N, Toba K, Freeman S, et al. Fall prevention using olfactory stimulation with lavender odor in elderly nursing home residents: a randomized controlled trial. Journal of the American Geriatrics Society 2012;60(6):1005-11. - PubMed
Snow 2004 {published data only}
    1. Snow AL, Hovanec L, Brandt J. A controlled trial of aromatherapy for agitation in nursing home patients with dementia. Journal of Alternative and Complementary Medicine 2004;10(3):431-7. - PubMed
Tsolaki 2016 {published data only}
    1. Tsolaki M, Karathanasi E, Lazarou I, Dovas K, Verykouki E, Karacostas A, Georgiadis K, Tsolaki A, Adam K, Kompatsiaris I, Sinakos Z. Efficacy and safety of Crocus sativus L. in patients with mild cognitive impairment: one year single-blind randomized, with parallel groups, clinical trial. Journal of Alzheimer's disease 2016;54(1):129-33. - PubMed
UMIN000019044 {published data only}
    1. UMIN000019044. The effectiveness of the bath powder which added aroma oil in Alzheimer's disease. upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022012 (first received 16 September 2015).
UMIN000027692 {published data only}
    1. UMIN000027692. Examination of the influence for cognitive function of aromatherapy using the essential oil which was extracted from Abies sachalinensis [Examination of the aromatherapy using the essential oil which was extracted from Abies sachalinensis]. upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031721 (first received 09 June 2017).
UMIN000027693 {published data only}
    1. UMIN000027693. Examination of the influence for cognitive function of aromatherapy using the essential oil which was extracted from natural green tea leaf [Examination of the aromatherapy using the essential oil which was extracted from natural green tea leaf]. upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031722 (first received 19 June 2017).
Watanabe 2010 {published data only}
    1. Watanabe S, Iino H, Miyajima M, Hara K, Ohta K, Matsuda A, et al. The effect of ylang-ylang aroma on auditory p300 event-related potentials in temporal lobe epilepsy. In: Epilepsy Currents. Vol. Conference: 64th Annual Meeting of the American Epilepsy Society, AES and 3rd Biennial North American Regional Epilepsy Congress San Antonio, TX United States. Conference Start: 20101203 Conference End: 20101207. Conference Publication. 2010:1.
West 1994 {published data only}
    1. West BJM, Brockman SJ. The calming power of aromatherapy. Journal of Dementia Care 1994;March/April(2):20-2.
Wolfe 1996 {published data only}
    1. Wolfe, N, Herzberg J. Can aromatherapy oils promote sleep in severely demented patients? International Journal of Geriatric Psychiatry 1996;11(10):926-7.
Woods 1996 {published data only}
    1. Woods DL, Craven R, Whitney J. The effects of therapeutic touch on disruptive behaviours of individuals with dementia of the Alzheimer's type. Alternative Therapies 1996;4(2):95-6.
Zalomonson 2019 {published data only}
    1. Zalomonson S, Freud T, Punchik B, Samson T, Lebedinsky S, Press Y. The results of a crossover placebo-controlled study of the effect of lavender oil on behavioral and psychological symptoms of dementia. Rejuvenation Research 2019;22(3):246-53. - PubMed

References to studies awaiting assessment

ISRCTN86563511 {published data only}ISRCTN86563511
    1. ISRCTN86563511. Investigating cognitive effects of aromatherapy on people with dementia living in residential care facilities. www.isrctn.com/ISRCTN86563511 (first received 09 June 2005).
NCT03576170 {published data only}
    1. NCT03576170. Investigate the efficacy and effectiveness of aromatherapy for the management of behavioral and psychological symptoms of dementia. clinicaltrials.gov/ct2/show/NCT03576170 (first received 03 July 2018).
NCT03662360 {published data only}
    1. NCT03662360. Elderly demented patient: aromatherapy complementary to psychopharmacotherapy psychological disorders and BPSD behavior [Elderly patient with dementia in the department of acute geriatrics: pilot study, monocentric, randomized use of aromatherapy as a complementary treatment to psychopharmacotherapy in psychological disorders and BPSD behavior]. clinicaltrials.gov/ct2/show/NCT03662360 (first received 07 September 2018).
UMIN000020148 {published data only}
    1. UMIN000020148. Effect of Aroma hand massage on the improvement of cognitive function. upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020662 (first received 10 December 2012).
UMIN000026366 {published data only}
    1. UMIN000026366. Study on effect of aroma foot massage on cognitive function. rctportal.niph.go.jp/detail/um?trial_id=UMIN000026366 (first received 01 April 2017).
Yoshiyama 2015 {published data only}
    1. Yoshiyama K, Arita H, Suzuki J. The effect of aroma hand massage therapy for dementia patients. In: Integrative Medicine Research. Vol. 4. 2015:93-4. [DOI: 10.1016/j/imr.2015.04.151] - DOI - PubMed
    1. Yoshiyama K, Arita H, Suzuki J. The effect of aroma hand massage therapy for people with dementia. Journal of Alternative and Complementary Medicine 2015;21(12):759-65. - PubMed

References to ongoing studies

ACTRN12617001159347 {published data only}
    1. ACTRN12617001159347. Essential oils for agitation in dementia (rELOAD) trial [The effectiveness of topical essential oils for agitation in dementia: a cluster-randomised, placebo-controlled feasibility trial]. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373424 (first received 03 August 2017).
ChiCTR‐INR‐17013281 {published data only}
    1. ChiCTR-INR-17013281. Comparison of the effects of aroma-laser acupuncture and aromatherapy on depression in dementia patients. www.chictr.org.cn/showproj.aspx?proj=22768 (first received 07 November 2017).

Additional references

Alzheimer's Society 2014
    1. Alzheimer's Society. Alzheimer's Society's view on complementary medicine / alternative therapies. www.alzheimers.org.uk/about-us/policy-and-influencing/what-we-think/alte... (accessed 03 August 2020).
APA 1994
    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
Arai 1997
    1. Arai Y, MD KK, Hosokawa T, Washio M, Miura H, Hisamichi S. Reliability and validity of the Japanese version of the Zarit Caregiver Burden Interview. Psychiatry and clinical neurosciences 1997;51(5):281-7. - PubMed
Arruda 2012
    1. Arruda M, Viana H, Rainha N, Neng NR, Rosa JS, Nogueira JMF, do Carmo Barreto M, et al. Anti-acetylcholinesterase and antioxidant activity of essential oils from Hedychium gardnerianum Sheppard ex Ker-Gawl. Molecules 2012;17(3):3082-92. - PMC - PubMed
Barnes 2003
    1. Barnes J. Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. regulation and quality. Pharmacology Research and Perspectives 2003;55(3):226-33. - PMC - PubMed
Bathini 2019
    1. Bathini P, Brai E, Auber L. Olfactory dysfunction in the pathophysiological continuum of dementia. Ageing Research Reviews 2019;55:100956. - PubMed
Battle 2019
    1. Battle CE, Abdul-Rahim AH, Shenkin SD, Hewitt J, Quinn TJ. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. Cochrane Database of Systematic Reviews 2019, Issue 4. Art. No: CD013306. [DOI: 10.1002/14651858.CD013306] - DOI - PMC - PubMed
Birks 2006
    1. Birks JS. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No: CD005593. [DOI: 10.1002/14651858.CD005593] - DOI - PMC - PubMed
Birks 2015
    1. Birks JS, Chong LY, Grimley Evans J. Rivastigmine for Alzheimer's disease. Cochrane Database of Systematic Reviews 215, Issue 9. Art. No: CD001191. [DOI: 10.1002/14651858.CD001191.pub4] - DOI - PMC - PubMed
Birks 2018
    1. Birks JS, Harvey RJ. Donepezil for dementia due to Alzheimer's disease. Cochrane Database of Systematic Reviews 2018, Issue 6. Art. No: CD001190. [DOI: 10.1002/14651858.CD001190.pub3] - DOI - PMC - PubMed
Blau 1977
    1. Blau T. Quality of life, social indicators, and criteria of change. Professional Psychology 1977;8:464-73.
Buckle 2003
    1. Buckle J. Clinical Aromatherapy: Essential Oils in Practice. 2nd edition. Elsevier, 2003.
Cheng 2017
    1. Cheng S. Dementia caregiver burden: a research update and critical analysis. Current Psychiatry Report 2017;19(9):64. - PMC - PubMed
Cohen‐Mansfield 1999
    1. Cohen-Mansfield J. Measurement of inappropriate behaviour associated with dementia. Journal of Gerontological Nursing 1999;25(2):42-51. - PubMed
Cummings 1994
    1. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44(12):2308-14. - PubMed
Degel 2001
    1. Degel J, Piper D, Koster EG. Implicit learning and implicit memory for odors: the influence of odor identification and retention time. Chemical Senses 2001;26(3):267-80. - PubMed
Directive 2004/24/EC
    1. Directive 2004/24/EC. Directive 2004/24/E of the European Parliament and Council of 31 March 2004, amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. L 136/34- L 136/5. eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:136:0085:0090:E... (accessed 10 August 2020).
Fleischman 2005
    1. Fleischman DA, Wilson RS, Gabrieli JD, Schneider JA, Bienias JL, Bennett DA. Implicit memory and Alzheimer’s disease neuropathy. Brain 2005;128:2006-15. - PubMed
Folstein 1975
    1. Folstein NF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975;12(3):189-98. - PubMed
Harris 2012
    1. Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. International Journal of Clinical Practice 2012;66(10):924-939. - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Holmes 2004
    1. Homes C, Ballard C. Aromatherapy in dementia. Advances In Psychiatric Treatment 2004;10(4):296-300.
Hughes 1982
    1. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. British Journal of Psychiatry 1982;140(6):556-72. - PubMed
Hwang 2015
    1. Hwang E, Shin S. The effects of aromatherapy on sleep improvement: a systematic literature review and meta-analysis. The Journal of Alternative and Complementary Medicine 2015;21(2):61-8. - PubMed
Kales 2015
    1. Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioural and psychological symptoms of dementia. BMJ 2015;350:h369. - PMC - PubMed
Kim 2019
    1. Kim EK, Park H, Lee CH, Park E. Effects of aromatherapy on agitation in patients with dementia: a systematic literature review and meta-analysis. Journal of Korean Academy of Community Health Nursing 2019;30(2):183-194.
Kitwood 1992
    1. Kitwood T. A new approach to the evaluation of dementia care. J Adv Health Nurs Care 1992;1(5):41-60.
Kong 2009
    1. Kong E-H, Evans LK, Guevara JP. Nonpharmacological intervention for agitation in dementia: a systematic review and meta-analysis. Aging and Mental Health 2009;13(4):512-20. - PubMed
Lawton 1996
    1. Lawton MP, Van Haitsma K, Klapper, J. Observed affect in nursing home residents with Alzheimer's disease. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences 1996;51(1):3-14. - PubMed
Leng 2019
    1. Leng M, Zhao Y, Wang Z. Comparative efficacy of non-pharmacological interventions on agitation in people with dementia: A systematic review and Bayesian network meta-analysis. International Journal of Nursing Studies 2019;102:103489. - PubMed
Lin 2008
    1. Lin JN, Wang JJ. Psychometric evaluation of the Chinese version of the Cornell Scale for depression in dementia. Journal of Nursing Research 2008;16(3):202-10. - PubMed
Livingston 2014
    1. Livingston G, Kelly L, Lewis-Holmes E, Baio G, Morris S, Patel N, Omar RZ, Katona C, Cooper C. Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials. The British Journal of Psychiatry 2014;205(6):436-442. - PubMed
Mahoney 1965
    1. Mahoney F, Barthel D. Functional evaluation: the Barthel Index: a simple index of independence useful in scoring improvement in the rehabilitation of the chronically ill. Maryland State Medical Journal 1965;14:56-61. - PubMed
McShane 2019
    1. McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, Maayan N, Ware J, Debarros J. Memantine for dementia. Cochrane Database of Systematic Reviews 2019, Issue 3. Art. No: CD003154. [DOI: 10.1002/14651858.CD003154.pub6] - DOI - PMC - PubMed
Nguyen 2008
    1. Nguyen QA, Paton C. The use of aromatherapy to treat behavioural problems in dementia. International Journal of Geriatric Psychiatry 2008;23(4):337-46. - PubMed
NICE 2018
    1. NICE. Dementia: assessment, management and support for people living with dementia and their carers. www.nice.org.uk/guidance/ng97 (accessed 02 February 2019).
Oliveira 2015
    1. Oliveira AM, Radanovic M, Mello PC, Buchain PC, Vizzotto AD, Celestino DL, Stella F, Piersol CV, Forlenza OV. Nonpharmacological interventions to reduce behavioral and psychological symptoms of dementia: a systematic review. BioMed research international 2015:1-9. [DOI: 10.1155/2015/218980] - DOI - PMC - PubMed
OnHealth 2020
    1. OnHealth with WebMD. Alternative Practices. web.archive.org/web/20010210192900/http://onhealth.webmd.com/alternative... (accessed 10 August 2020).
Perry 2006
    1. Perry E. Aromatherapy for the treatment of Alzheimer's disease. The Journal of Quality Research In Dementia Issues 2006:3-6.
Posadzki 2012
    1. Posadzki P, Alotaibi A, Ernst E. Adverse effects of aromatherapy: A systematic review of case reports and case series. International Journal of Risk and Safety in Medicine 2012;24(3):147-61. - PubMed
Prince 2015
    1. Prince MJ, Wimo A, Guerchet MM, Ali GC, Wu YT, Prina M. The global impact of dementia: An analysis of prevalence, incidence, cost and trends. World Alzheimer Report. London: Alzheimer's Disease International 2015.
Reus 2016
    1. Reus VI, Fochtmann LJ, Eyler AE, Hilty DM, Horvitz-Lennon M, Jibson MD, et al. The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. American Journal of Psychiatry 2016;173(5):543-6. - PubMed
Review Manager 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rosen 1984
    1. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. The American journal of psychiatry 1984;141(11):1356–64. - PubMed
Rosen 1994
    1. Rosen J, Burgio L, Kollar M, Cain M, Allison M, Fogleman M, et al. The Pittsburg Agitation Scale: a user friendly instrument for rating agitation in dementia. American Journal of Geriatric Psychiatry 1994;2(1):52-9. - PubMed
SAS® 1999 [Computer program]
    1. SAS Institute Inc. SAS/STAT User's Guide, Version 8. Cary, NC: SAS Institute Inc., 1999.
Schünemann 2008
    1. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S, editors(s). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008:359-83.
Shinde 2009
    1. Shinde VM, Dhalwal K, Potdar M, Mahadik KR. Application of quality control principles to herbal drugs. International Journal of Phytomedicine 2009;1(1):4-8.
Spirit Scents 2020
    1. Spirit Scents. Aromatherapy matrix of essential oils by therapeutic effect. www.spiritscents.com/matrix.html (accessed 10 August 2020).
Tisserand 1988
    1. Tisserand R. Aromatherapy for Everyone. London: Penguin, 1988.
Turek 2013
    1. Turek C, Stintzing FC. Stability of essential oils: a review. Comprehensive Reviews In Food Science and Food Safety 2013;12(1):40-53.
WHO 1993
    1. World Health Organization. The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research. Geneva: World Health Organization, 1993.
WHO 2019
    1. WHO 2019. Dementia: Key Facts. www.who.int/news-room/fact-sheets/detail/dementia#:~:text=Worldwide%2C%2.... (accessed 03 August 2020).

References to other published versions of this review

Forrester 2014
    1. Forrester LT, Maayan N, Orrell M, Spector AE, Buchan LD, Soares-Weiser K. Aromatherapy for dementia. Cochrane Database of Systematic Reviews 2014, Issue 2. Art. No: CD003150. [DOI: 10.1002/14651858.CD003150.pub2] - DOI - PubMed
Thorgrimsen 2003
    1. Thorgrimsen LM, Spector AE, Wiles A, Orrell M. Aromatherapy for dementia. Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No: CD003150. [DOI: 10.1002/14651858.CD003150] - DOI - PubMed

Publication types

Associated data